A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications.

Journal Information

Full Title: Mol Ther Methods Clin Dev

Abbreviation: Mol Ther Methods Clin Dev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"the raw and processed scrna-seq data generated in this study will be deposited in the gene expression omnibus under accession number gse234778 ."

Code Sharing
Evidence found in paper:

"Declaration of interests The authors declare no competing interests."

Evidence found in paper:

"We thank the Genomics Facility Basel and FACS Core facility of the Department of Biomedicine, University Hospital of Basel, for excellent support and assistance throughout this study. Acknowledgments go to the blood donors, and to Dr. Glenn Bantug for providing the EBV strain. This work was supported by the Swiss National Foundation Grant 32003B_204944 (to N.K.), NCCR Antiresist Grant No. 180541, Switzerland (to N.K.), Bangerter–Rhyner Stiftung (to N.K.), 10.13039/501100003006ETH Zurich Post-doctoral Fellowship, Switzerland (to R.B.D.R.), 10.13039/501100013850Helmut Horten Stiftung, Switzerland (to S.T.R.), and NCCR Molecular Systems Engineering, Switzerland (to S.T.R.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025